Maria - Survivor of MonoMAC Syndrome
Add to My Pictures
|Title:||Maria - Survivor of MonoMAC Syndrome|
Maria was diagnosed with MonoMAC syndrome (a GATA2 deficiency) at the National Institutes of Health Clinical Center and participated in an NCI clinical trial involving chemotherapy and bone marrow transplant. The treatment prevented her from getting leukemia, a cancer for which people with MonoMAC syndrome individuals are predisposed.
Social media crops below, as attachments.
This image is part of the NCI Annual Plan and Budget Proposal FY 2022 collection.
See also www.cancer.gov/about-nci/budget/plan/.
|Type:||Color, Illustration (JPEG format)|
|Source:||National Cancer Institute (NCI)|
|Date Created:||September 1, 2020|
|Date Added:||September 1, 2020|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|